Skip to main content

PulseHaler™: A Novel Treatment Device for COPD.

Project description

New solution brings relief to chronic lung disease sufferers

The EU-funded STOP-COPD project has developed a novel device, called PulseHaler™, to treat chronic obstructive pulmonary disease (COPD), a progressive disease of the lungs. The device successfully opens the small airways, which are known to collapse in COPD patients, making it difficult for them to breathe. PulseHaler™ improves the exercise capacity, reduces breathlessness, and improves quality of life of COPD sufferers. Researchers will optimise the device with new features and functions and prepare it for large-scale manufacturing. Given the millions of COPD patients in Europe alone, the device has the potential to substantially reduce associated healthcare costs.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 2 414 365,63
8 Hachoshlim St.
4672408 Herzliya Pituach

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 1 034 728,12